vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Acushnet Holdings Corp. (GOLF). Click either name above to swap in a different company.
Acushnet Holdings Corp. is the larger business by last-quarter revenue ($477.2M vs $284.0M, roughly 1.7× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -7.3%, a 103.6% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 7.2%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -17.9%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
The Acushnet Company is an American company focused on the golf market. The company operates a series of brands that manufacture golf equipment, clothing and accessories.
ACAD vs GOLF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $477.2M |
| Net Profit | $273.6M | $-34.9M |
| Gross Margin | 90.8% | 44.1% |
| Operating Margin | 6.1% | -3.8% |
| Net Margin | 96.3% | -7.3% |
| Revenue YoY | 9.4% | 7.2% |
| Net Profit YoY | 90.3% | -3027.3% |
| EPS (diluted) | $1.61 | $-0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $477.2M | ||
| Q3 25 | $278.6M | $657.7M | ||
| Q2 25 | $264.6M | $720.5M | ||
| Q1 25 | $244.3M | $703.4M | ||
| Q4 24 | $259.6M | $445.2M | ||
| Q3 24 | $250.4M | $620.5M | ||
| Q2 24 | $242.0M | $683.9M | ||
| Q1 24 | $205.8M | $707.6M |
| Q4 25 | $273.6M | $-34.9M | ||
| Q3 25 | $71.8M | $48.5M | ||
| Q2 25 | $26.7M | $75.6M | ||
| Q1 25 | $19.0M | $99.4M | ||
| Q4 24 | $143.7M | $-1.1M | ||
| Q3 24 | $32.8M | $56.2M | ||
| Q2 24 | $33.4M | $71.4M | ||
| Q1 24 | $16.6M | $87.8M |
| Q4 25 | 90.8% | 44.1% | ||
| Q3 25 | 92.2% | 48.5% | ||
| Q2 25 | 92.2% | 49.2% | ||
| Q1 25 | 91.7% | 47.9% | ||
| Q4 24 | 91.6% | 22.6% | ||
| Q3 24 | 92.5% | 54.4% | ||
| Q2 24 | 92.5% | 54.4% | ||
| Q1 24 | 88.8% | 53.4% |
| Q4 25 | 6.1% | -3.8% | ||
| Q3 25 | 12.8% | 14.1% | ||
| Q2 25 | 12.2% | 15.2% | ||
| Q1 25 | 7.9% | 16.3% | ||
| Q4 24 | 59.1% | -1.2% | ||
| Q3 24 | 12.6% | 13.2% | ||
| Q2 24 | 12.6% | 15.5% | ||
| Q1 24 | 7.4% | 17.2% |
| Q4 25 | 96.3% | -7.3% | ||
| Q3 25 | 25.8% | 7.4% | ||
| Q2 25 | 10.1% | 10.5% | ||
| Q1 25 | 7.8% | 14.1% | ||
| Q4 24 | 55.4% | -0.3% | ||
| Q3 24 | 13.1% | 9.1% | ||
| Q2 24 | 13.8% | 10.4% | ||
| Q1 24 | 8.0% | 12.4% |
| Q4 25 | $1.61 | $-0.57 | ||
| Q3 25 | $0.42 | $0.81 | ||
| Q2 25 | $0.16 | $1.25 | ||
| Q1 25 | $0.11 | $1.62 | ||
| Q4 24 | $0.86 | $0.02 | ||
| Q3 24 | $0.20 | $0.89 | ||
| Q2 24 | $0.20 | $1.11 | ||
| Q1 24 | $0.10 | $1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | — |
| Total DebtLower is stronger | — | $926.2M |
| Stockholders' EquityBook value | $1.2B | $783.6M |
| Total Assets | $1.6B | $2.3B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — | ||
| Q1 24 | $204.7M | — |
| Q4 25 | — | $926.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $753.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $783.6M | ||
| Q3 25 | $917.3M | $852.3M | ||
| Q2 25 | $822.4M | $808.5M | ||
| Q1 25 | $765.2M | $780.3M | ||
| Q4 24 | $732.8M | $765.2M | ||
| Q3 24 | $577.2M | $863.9M | ||
| Q2 24 | $516.7M | $863.7M | ||
| Q1 24 | $464.0M | $883.7M |
| Q4 25 | $1.6B | $2.3B | ||
| Q3 25 | $1.3B | $2.4B | ||
| Q2 25 | $1.2B | $2.4B | ||
| Q1 25 | $1.1B | $2.4B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | $976.9M | $2.3B | ||
| Q2 24 | $914.1M | $2.3B | ||
| Q1 24 | $855.1M | $2.4B |
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-338.0K |
| Free Cash FlowOCF − Capex | — | $-23.3M |
| FCF MarginFCF / Revenue | — | -4.9% |
| Capex IntensityCapex / Revenue | — | 4.8% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $120.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-338.0K | ||
| Q3 25 | $74.3M | $163.1M | ||
| Q2 25 | $64.0M | $151.9M | ||
| Q1 25 | $20.3M | $-120.3M | ||
| Q4 24 | $40.4M | $-1.1M | ||
| Q3 24 | $63.2M | $144.1M | ||
| Q2 24 | $25.0M | $211.6M | ||
| Q1 24 | $29.1M | $-109.5M |
| Q4 25 | — | $-23.3M | ||
| Q3 25 | $73.9M | $136.9M | ||
| Q2 25 | — | $138.0M | ||
| Q1 25 | — | $-131.5M | ||
| Q4 24 | — | $-33.2M | ||
| Q3 24 | $63.2M | $123.7M | ||
| Q2 24 | — | $196.8M | ||
| Q1 24 | — | $-116.8M |
| Q4 25 | — | -4.9% | ||
| Q3 25 | 26.5% | 20.8% | ||
| Q2 25 | — | 19.2% | ||
| Q1 25 | — | -18.7% | ||
| Q4 24 | — | -7.5% | ||
| Q3 24 | 25.2% | 19.9% | ||
| Q2 24 | — | 28.8% | ||
| Q1 24 | — | -16.5% |
| Q4 25 | — | 4.8% | ||
| Q3 25 | 0.1% | 4.0% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | 0.0% | 3.3% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 3.36× | ||
| Q2 25 | 2.40× | 2.01× | ||
| Q1 25 | 1.07× | -1.21× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 2.56× | ||
| Q2 24 | 0.75× | 2.96× | ||
| Q1 24 | 1.76× | -1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
GOLF
| Titleist Golf Equipment | $293.8M | 62% |
| Footjoy Golf Wear | $102.0M | 21% |
| Other | $45.3M | 9% |
| Golf Gear | $36.1M | 8% |
